MAPK3 and diabetes mellitus: In summary, these findings suggest that inhibition of ERK1/2 mediated by HDAC inhibitor might be one of the important regulatory mechanisms of hypertrophy induced by different stimuli, which might provide a new target for therapies against cardiac complications induced by diabetes.